Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints

Shelby Livingston / endpoints - With insurance coverage of weight loss medications stalled, Eli Lilly has developed a program to give employers another way to pay for their workers' GLP-1 treatments. The pharma giant on Thursday announced the launch of ...

#obesity #healthcare #pharmaceuticals #drugpricing #elililly #weightloss #healthcarefinance

GLP-1 medication changes may support long-term weight management

14 hrs / medicalxpress

Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists

15 hrs / medicalxpress

2018 to 2025 saw rise in GLP-1 receptor agonist Rx for bariatric surgery-eligible patients

17 hrs / medicalxpress

Carrum Health teams up with Virta Health on a comprehensive weight loss solution

21 hrs / fiercehealthcare

Ascletis touts GLP-1 quarterly dosing data; Mineralys apnea Phase 2 misses

22 hrs / endpoints / ENDPOINTS

Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males

32 hrs / medicalxpress

Digital nudges help GLP-1 users: Stanford

40 hrs / beckershospitalreview / Giles Bruce

Hims & Hers makes deal with Novo Nordisk as it shifts obesity strategy

44 hrs / fiercehealthcare

10 drugs poised to be global best-sellers in 2030

45 hrs / beckershospitalreview / Paige Twenter

AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China

46 hrs / endpoints / ENDPOINTS

Amazon Pharmacy expands Zepbound access

47 hrs / beckershospitalreview / Ella Jeffries

Hims agrees to limit compounding, ending feud with Novo Nordisk

47 hrs / endpoints / Shelby Livingston

Novo, Hims strike GLP-1 deal after legal feud

2 days / beckershospitalreview / Ella Jeffries

Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

2 days / medcitynews / Frank Vinluan

Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says

5 days / medcitynews / Marissa Plescia

Eli Lilly's new program aims to boost employer coverage of GLP-1s

5 days / endpoints / Shelby Livingston

Saturday, March 7, 2026, 10:21 pm / permalink 20341 / 16 stories in 3 days

Related Stories

Related Tags

Obesity

GLP‑1 drugs associated with lower addiction risk in large study (4 days)

Novo Nordisk commits $2.1B to Vivtex to pursue oral obesity medicines (8 days)

Lilly’s Zepbound bests Novo’s CagriSema in head‑to‑head obesity trial (13 days)

Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (19 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (38 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare

Pharmaceuticals

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes (3 days)

more #pharmaceuticals

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.